Quidel received Emergency Authorization for rapid antigen ‘ABC test’ assay for Influenza A+B and COVID-19
On Oct. 2, 2020, Quidel announced that it had received Emergency Use Authorization from the U.S. Food and…
-
-
Bio-Techne announced opening of GMP manufacturing facility in Twin Cities
On Sept. 30, 2020, Bio-Techne announced the opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing…
-
Quest Diagnostics launched three new combined COVID-19 and respiratory virus tests
On Sept. 30, 2020, Quest Diagnostics announced three different test options for healthcare providers across the U.S.to aid…
-
BD announced CE Mark of portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes
On Sept. 30, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
-
Global partnership made available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries
On Sept. 28, 2020, the World Health Organization (WHO) announced agreements to make available, for low and middle-income…
-
Regular COVID-19 testing for groups most likely to spread the virus more efficient, cost-effective than random testing
On Sept. 28, 2020, as COVID-19 infections began to rise again, a novel testing strategy was proposed by…
-
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease
Hologic granted FDA Emergency Use Authorization for asymptomatic COVID-19 testing with Panther Fusion SARS-CoV-2 assay
On Sept. 28, 2020, Hologic announced that its Panther Fusion SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
-
Evaluation of LamPORE rapid tests for Covid-19 showed high levels of diagnostic sensitivity
On Sept. 25, 2020, scientists from the University of Oxford’s Nuffield Department of Medicine published their evaluation of…
-
Todos Medical entered Into COVID-19 PCR testing implementation and equipment financing partnership with AID Genomics
On Sept. 25, 2020, Todos Medical announced that it had entered into an implementation and equipment financing partnership…
-
Lumen Bioscience awarded Federal grant to rapidly develop antibody-based Covid-19 therapeutic
On Sept. 24, 2020, Lumen Bioscience and the US Army Medical Research and Development Command, announced an agreement…
-
Yale designated labs in three states to provide SalivaDirect COVID-19 test
On Sept. 24, 2020, Yale University announced it had designated three independent laboratories to perform the university-developed SalivaDirect…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science History | Therapeutics | Vaccine | WHO
Countries urged to take stronger action to stop spread of harmful COVID-19 pandemic information
On Sept. 23, 2020, the World Health Organization (WHO) with the United Nations, specialised agencies and partners called…
-
FDA authorized first point-of-care antibody test for COVID-19
On Sept. 23, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
-
FDA launched the Digital Health Center of Excellence
On Sept. 22, 2020, the U.S. Food and Drug Administration (FDA) the launch of the Digital Health Center…
-
Oxford Immunotec joined with Public Health England in large clinical trial utilizing T-SPOT discovery SARS-CoV-2 test
On Sept. 22, 2020, Oxford Immunotec announced that it had entered into an extensive research collaboration with Public…
-
Study found that children’s immune response protected against COVID-19
On Sept. 21, 2020, the first study comparing the immune responses of adults and children with COVID-19 has…
-
Biotechnology | COVID-19 | CRISPR | Diagnostics | HIV | Infectious Disease
UConn researchers validate clinical feasibility for COVID-19 testing at point of care
On Sept. 18, 2020, Uconn researchers, in a paper published in Nature Communications, validated the clinical feasibility of…
-
Rigel announced NIH/NHLBI-sponsored trial of fostamatinib in hospitalized COVID-19 patients in collaboration with Inova
On Sept. 17, 2020, Rigel Pharma announced the start of a multicenter, Phase 2 trial to evaluate the…
-
MIT and the Broad Institute Developed Rapid test for COVID-19 showed improved sensitivity
On Sept. 17, 2020, researchers announced a CRISPR-based test developed at MIT and the Broad Institute that can…
-
Quest Diagnostics announced COVID-19 Diagnostic test options for active COVID-19 infection through QuestDirect
On Sept. 17, 2020, Quest Diagnostics announced that individuals can purchase a test to diagnose COVID-19 online, without…
-
3CL protease inhibitor NLC-001 added to COVID-19-focused joint venture between Todos Medical and NLC Pharma
On Sept. 17, 2020, Todos Medical announced that NLC Pharma had added the dietary supplement NLC-001 to its…
-
NIH funded community engagement research efforts in areas hardest hit by COVID-19
On Sept. 16, 2020, the National Institutes of Health (NIH) announced a $12 million award for outreach and…
-
Lilly announced proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting
On Sept. 16, 2020, Eli Lilly announced proof of concept data from an interim analysis of the BLAZE-1…
-
AXIM Biotechnologies filed Emergency Use Authorization with COVID-19 rapid diagnostic test for neutralizing antibodies
On Sept. 16, 2020, AXIM Biotechnologies announced that it had filed an Emergency Use Authorization (EUA) application with…
-
Thermo Fisher Scientific further expanded laboratory plastics production to support COVID-19 testing, therapies and vaccines
On Sept. 15, 2020, Thermo Fisher Scientific announced it was investing more than $140 million to further expand…
-
Soligenix announced publication demonstrating thermostabilization of filovirus vaccine antigens
On Sept. 15, 2020, Soligenix, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare…
-
UTHealth joined NIH trial to test antibodies and other experimental outpatient treatments for COVID-19 pneumonia
On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study…
-
Arizona COVID-19 Genomics Union tracked strains of SARS-CoV-2
On Sept. 15, 2020, initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggested that following Arizona’s…
-
New anti-infective drugs had a 14% speed advantage vs other drugs from 2000-2019
On Sept. 15, 2020, the Tufts Center for the Study of Drug Development reported that new anti-infective drugs…
-
FDA contracted with global partners to analyze coronavirus samples
On Sept. 15, 2020, the U.S. Food and Drug Administration (FDA) awarded a $5.4 million research contract to…
